ARTICLE

JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice

Prepared by: British Cardiac Society, British Hypertension Society, Diabetes UK, HEART UK, Primary Care Cardiovascular Society, The Stroke Association

Correspondence to:
Correspondence to:
Professor David A Wood
Cardiovascular Medicine, National Heart and Lung Institute, Imperial College, Charing Cross Hospital, 5th Floor, Laboratory Block, Fulham Palace Road, London W6 8RF, UK; d.wood@imperial.ac.uk

Keywords: Joint British Societies; cardiovascular disease prevention; Joint British Societies’ guidelines; prevention of cardiovascular disease; clinical practice

The first 150 words of the full text of this article appear below.

The Joint British Societies’ guidelines (JBS 2) on cardiovascular disease prevention in clinical practice were developed by a Working Party (see table) with nominated representatives from six professional societies. All members contributed to the text and those from the specialist societies of hypertension, lipids, and diabetes were specifically responsible for developing the sections on blood pressure, lipids, and glucose. All sections of the document represent an evidence based consensus by all professional societies involved. The scientific literature which informs the recommendations is referenced throughout the text and Dr Kornelia Kotseva is thanked for all her help in searches for systematic reviews and meta-analyses, and checking the referencing of all sections. We are grateful to both Mr Harry Heyes of the Department of Medical Illustration, University of Manchester, for the cardiovascular risk prediction charts artwork, and Mr Daniel Prais of Crawford’s Business Services, Salford, for the computer programming. Dr Paola Primatesta . . . [Full text of this article]

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Relevant Articles

WEB TOP 10
Heart 2007 93: 257. [Extract] [Full Text] [PDF]

Web Top 10
Heart 2007 93: 116. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

• Bond, R. (2009). Management of hypertension. InnovAiT 2: 714-720 [Abstract] [Full Text]  
• (2009). Aspirin for primary prevention of cardiovascular disease?. DTB 47: 122-125 [Abstract] [Full Text]  
• Song, S.H., Hardisty, C.A. (2009). Early onset type 2 diabetes mellitus: a harbinger for complications in later years--clinical observation from a secondary care cohort. QJM 102: 799-806 [Abstract] [Full Text]  
• Redberg, R. F., Benjamin, E. J., Bittner, V., Braun, L. T., Goff, D. C. Jr, Havas, S., Labarthe, D. R., Limacher, M. C., Lloyd-Jones, D. M., Mora, S., Pearson, T. A., Radford, M. J., Smetana, G. W., Spertus, J. A., Swegler, E. W. (2009). ACCF/AHA 2009 performance measures for primary prevention of cardiovascular disease in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Performance Measures for Primary Prevention of Cardiovascular Disease) developed in collaboration with the American Academy of Family Physicians; American Association of Cardiovascular and Pulmonary Rehabilitation; and Preventive Cardiovascular Nurses Association Endorsed by the American College of Preventive Medicine, American College of Sports Medicine, and Society for Women's Health Research.. J Am Coll Cardiol 54: 1364-1405 [Full Text]  
• WRITING COMMITTEE MEMBERS, , Redberg, R. F., Benjamin, E. J., Bittner, V., Braun, L. T., Goff, D. C. Jr, Havas, S., Labarthe, D. R., Limacher, M. C., Lloyd-Jones, D. M., Mora, S., Pearson, T. A., Radford, M. J., Smetana, G. W., Spertus, J. A., Swegler, E. W. (2009). ACCF/AHA 2009 Performance Measures for Primary Prevention of Cardiovascular Disease in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Performance Measures for Primary Prevention of Cardiovascular Disease): Developed in Collaboration With the American Academy of Family Physicians; American Association of Cardiovascular and Pulmonary Rehabilitation; and Preventive Cardiovascular Nurses Association: Endorsed by the American College of Preventive Medicine, American College of Sports Medicine, and Society for Women's Health Research. Circulation 120: 1296-1336 [Full Text]  
• Parish, S., Peto, R., Palmer, A., Clarke, R., Lewington, S., Offer, A., Whitlock, G., Clark, S., Youngman, L., Sleight, P., Collins, R., for the International Studies of Infarct Survival, (2009). The joint effects of apolipoprotein B, apolipoprotein A1, LDL cholesterol, and HDL cholesterol on risk: 3510 cases of acute myocardial infarction and 9805 controls. Eur Heart J 30: 2137-2146 [Abstract] [Full Text]  
• Marma, A. K., Lloyd-Jones, D. M. (2009). Systematic Examination of the Updated Framingham Heart Study General Cardiovascular Risk Profile. Circulation 120: 384-390 [Abstract] [Full Text]  
• Payne, R. A, Webb, D. J, Maxwell, S. R J (2009). Correction and transparency of BNF risk charts. BMJ 338: b2330-b2330 [Full Text]  
• Mallewa, J E, Higgins, S P, Garbett, S, Saxena, N, Vilar, F J (2009). Cardiovascular disease risk management in HIV patients, experiences from Greater Manchester. Int J STD AIDS 20: 425-426 [Abstract] [Full Text]  
• (2009). What role for {blacktriangledown}colesevelam in cardiovascular prevention?. DTB 47: 53-55 [Abstract] [Full Text]  
• Stamatakis, E, Hamer, M, Primatesta, P (2009). Cardiovascular medication, physical activity and mortality: cross-sectional population study with ongoing mortality follow-up. Heart 95: 448-453 [Abstract] [Full Text]  
• Song, S. H, Gray, T. A (2009). Management of type 2 diabetes and lipids: a critique of the NICE guidelines 2008. British Journal of Diabetes & Vascular Disease 9: 69-74 [Abstract]  
• Lancaster, T. (2009). Physician training in the use of a decision aid increased patient participation in decision making for CVD prevention. Evid. Based Med. 14: 24-24 [Full Text]  
• Sattar, N. (2009). Review: PCOS, insulin resistance and long-term risks for diabetes and vascular disease. British Journal of Diabetes & Vascular Disease 9: 15-18 [Abstract]  
• Bulugahapitiya, U., Siyambalapitiya, S., Sithole, J., Fernando, D. J, Idris, I. (2009). The clinical impact of identifying metabolic syndrome in patients with diabetes: a cross-sectional study. Diabetes and Vascular Disease Research 6: 21-24 [Abstract]  
• Saunders, S.A., Wallymhamed, M., Macfarlane, I.A. (2009). Improvements in glycaemic control and cardiovascular risk factors in a cohort of patients with type 1 diabetes over a 5-year period. QJM 102: 29-34 [Abstract] [Full Text]  
• McGeechan, K., Macaskill, P., Irwig, L., Liew, G., Wong, T. Y. (2008). Assessing New Biomarkers and Predictive Models for Use in Clinical Practice: A Clinician's Guide. Arch Intern Med 168: 2304-2310 [Abstract] [Full Text]  
• Mugarza, J. A, Wilding, J. P, Woodward, A., Hayden, K., Gill, G. V (2008). Achieving blood pressure control in patients with type 2 diabetes and diabetic renal disease by a nurse-led protocol based clinic. British Journal of Diabetes & Vascular Disease 8: 279-284 [Abstract]  
• Kuppuswamy, V., Mela, M., Eustace, I., Gupta, S. (2008). Meeting UK national targets for lipids in acute coronary syndrome with early and intensive lipid reduction: a single centre District general hospital experience. British Journal of Diabetes & Vascular Disease 8: 286-290 [Abstract]  
• Holt, T. A (2008). Detection of undiagnosed diabetes using UK general practice data. British Journal of Diabetes & Vascular Disease 8: 291-294 [Abstract]  
• Ferns, G, Keti, V, Griffin, B (2008). Investigation and management of hypertriglyceridaemia. J. Clin. Pathol. 61: 1174-1183 [Abstract] [Full Text]  
• Bulugahapitiya, U, Siyambalapitiya, S, Sithole, J, Fernando, D J, Idris, I (2008). Age threshold for vascular prophylaxis by aspirin in patients without diabetes. Heart 94: 1429-1432 [Abstract] [Full Text]  
• Belch, J., MacCuish, A., Campbell, I., Cobbe, S., Taylor, R., Prescott, R., Lee, R., Bancroft, J., MacEwan, S., Shepherd, J., Macfarlane, P., Morris, A., Jung, R., Kelly, C., Connacher, A., Peden, N., Jamieson, A., Matthews, D., Leese, G., McKnight, J., O'Brien, I., Semple, C., Petrie, J., Gordon, D., Pringle, S., MacWalter, R., Prevention of Progression of Arterial Disease and, (2008). The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease. BMJ 337: a1840-a1840 [Abstract] [Full Text]  
• Newman, C. B, Szarek, M., Colhoun, H. M, Betteridge, D J., Durrington, P. N, Hitman, G. A, Neil, H A. W, Demicco, D. A, Auster, S., Fuller, J. H (2008). The safety and tolerability of atorvastatin 10 mg in the Collaborative Atorvastatin Diabetes Study (CARDS). Diabetes and Vascular Disease Research 5: 177-183 [Abstract]  
• Reynolds, T. M., Mardani, A., Twomey, P. J., Wierzbicki, A. S. (2008). Targeted versus global approaches to the management of hypercholesterolaemia. The Journal of the Royal Society for the Promotion of Health 128: 248-254 [Abstract]  
• Bhatnagar, D., Soran, H., Durrington, P. N (2008). Hypercholesterolaemia and its management. BMJ 337: a993-a993 [Full Text]  
• Hooper, L., Kroon, P. A, Rimm, E. B, Cohn, J. S, Harvey, I., Le Cornu, K. A, Ryder, J. J, Hall, W. L, Cassidy, A. (2008). Flavonoids, flavonoid-rich foods, and cardiovascular risk: a meta-analysis of randomized controlled trials. Am. J. Clin. Nutr. 88: 38-50 [Abstract] [Full Text]  
• Dunning, J., Versteegh, M., Fabbri, A., Pavie, A., Kolh, P., Lockowandt, U., Nashef, S. A.M., on behalf of the EACTS Audit and Guidelines Commit, (2008). Guideline on antiplatelet and anticoagulation management in cardiac surgery.. Eur. J. Cardiothorac. Surg. 34: 73-92 [Abstract] [Full Text]  
• Wild, S., Byrne, C. D (2008). Time to rethink high-density lipoprotein?. Heart 94: 692-694 [Full Text]  
• Song, S.H., Hardisty, C.A. (2008). Diagnosing metabolic syndrome in type 2 diabetes: does it matter?. QJM 101: 487-491 [Abstract] [Full Text]  
• Gray, J, Jaiyeola, A, Whiting, M, Modell, M, Wierzbicki, A S (2008). Identifying patients with familial hypercholesterolaemia in primary care: an informatics-based approach in one primary care centre. Heart 94: 754-758 [Abstract] [Full Text]  
• Cappuccio, F. P (2008). Commentary: Controversies in NICE guidance on lipid modification for the prevention of cardiovascular disease. BMJ 336: 1248-1249 [Full Text]  
• Armitage, J (2008). Commentary on NICE technology appraisal guidance on ezetimibe for the treatment of primary (heterozygous-familial and non-familial) hypercholesterolaemia. Heart 94: 643-645 [Full Text]  
• van Hecke, O. (2008). Whose line is it anyway?. Psychiatr. Bull. 32: 198-198 [Full Text]  
• Petty, D., Lloyd, D. (2008). Can cheap generic statins achieve national cholesterol lowering targets?. J Health Serv Res Policy 13: 99-102 [Abstract] [Full Text]  
• Barnett, A. H (2008). The importance of treating cardiometabolic risk factors in patients with type 2 diabetes. Diabetes and Vascular Disease Research 5: 9-14 [Abstract]  
• Song, S. H (2008). Review: Early-onset type 2 diabetes mellitus: a condition with elevated cardiovascular risk?. British Journal of Diabetes & Vascular Disease 8: 61-65 [Abstract]  
• Peter, R, Cox, A, Evans, M (2008). Management of diabetes in cardiovascular patients. Heart 94: 369-375 [Full Text]  
• Patel, J.V., Lim, H.S., Gunarathne, A., Tracey, I., Durrington, P.N., Hughes, E.A., Lip, G.Y.H. (2008). Ethnic differences in myocardial infarction in patients with hypertension: effects of diabetes mellitus. QJM 101: 231-236 [Abstract] [Full Text]  
• Lau, K-K, Chan, Y-H, Yiu, K-H, Tam, S, Li, S-W, Lau, C-P, Tse, H-F (2008). Incremental predictive value of vascular assessments combined with the Framingham Risk Score for prediction of coronary events in subjects of low-intermediate risk. Postgrad. Med. J. 84: 153-157 [Abstract] [Full Text]  
• Ruiz-Nodar, J. M., Marin, F., Hurtado, J. A., Valencia, J., Pinar, E., Pineda, J., Gimeno, J. R., Sogorb, F., Valdes, M., Lip, G. Y.H. (2008). Anticoagulant and Antiplatelet Therapy Use in 426 Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention and Stent Implantation: Implications for Bleeding Risk and Prognosis. J Am Coll Cardiol 51: 818-825 [Abstract] [Full Text]  
• D'Agostino, R. B. Sr, Vasan, R. S., Pencina, M. J., Wolf, P. A., Cobain, M., Massaro, J. M., Kannel, W. B. (2008). General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study. Circulation 117: 743-753 [Abstract] [Full Text]  
• Turley, A J, Chen, V, Hall, J A (2008). Simultaneous presentation of coronary heart disease in identical twins. Postgrad. Med. J. 84: 100-102 [Abstract] [Full Text]  
• Seidel, B. M., Stocks, N. (2008). Estimating Cardiovascular Risk. Arch Intern Med 168: 111-111 [Full Text]  
• Preiss, D., Sattar, N. (2007). Metabolic syndrome, dysglycaemia and vascular disease: making sense of the evidence. Heart 93: 1493-1496 [Abstract] [Full Text]  
• Goenka, N., Thomas, S., Shaikh, S., Morrisey, J., Patel, V. (2007). Providing diabetes care to Arab migrants in the UK: cultural and clinical aspects. British Journal of Diabetes & Vascular Disease 7: 283-286 [Abstract]  
• Clark, C. E, Campbell, J. L, Powell, R. J, Thompson, J. F (2007). The inter-arm blood pressure difference and peripheral vascular disease: cross-sectional study. Fam Pract 24: 420-426 [Abstract] [Full Text]  
• Sleath, J. D (2007). Here's to risk assessment. BMJ 335: 577-578 [Full Text]  
• Wilding, J. P., Gause-Nilsson, I., Persson, A. (2007). Tesaglitazar, as add-on therapy to sulphonylurea, dose-dependently improves glucose and lipid abnormalities in patients with type 2 diabetes. Diabetes and Vascular Disease Research 4: 194-203 [Abstract]  
• Woodward, A., Bayley, D., Overend, L., Gill, G. (2007). Antiplatelet drug use in a diabetic clinic. QJM 100: 547-550 [Abstract] [Full Text]  
• Twomey, P J, Pledger, D R (2007). HDL-cholesterol and triglycerides: an overlooked issue?. J. Clin. Pathol. 60: 1065-1066 [Full Text]  
• Saweirs, W. W. M., Goddard, J. (2007). What are the best treatments for early chronic kidney disease?: A Background Paper prepared for the UK Consensus Conference on Early Chronic Kidney Disease. Nephrol Dial Transplant 22: ix31-ix38 [Full Text]  
• Hall, R., Saukko, P. M, Evans, P. H, Qureshi, N., Humphries, S. E (2007). Assessing family history of heart disease in primary care consultations: a qualitative study. Fam Pract 0: cmm037v1-cmm037 [Abstract] [Full Text]  
• Harper, J., Hodsman, A., Gilg, J., Ansell, D., Williams, A. J. (2007). Factors which may influence cardiovascular disease in dialysis and transplant patients blood pressure (Chapter 10). Nephrol Dial Transplant 22: vii119-vii137 [Abstract] [Full Text]  
• Deepak, D, Furlong, N J, Wilding, J P H, MacFarlane, I A (2007). Cardiovascular disease, hypertension, dyslipidaemia and obesity in patients with hypothalamic-pituitary disease. Postgrad. Med. J. 83: 277-280 [Abstract] [Full Text]  
• Chauhan, U. (2007). Cardiovascular disease prevention in primary care. Br Med Bull 0: ldm002v1-15 [Abstract] [Full Text]  
• Sattar, N., Murray, H. M., McConnachie, A., Blauw, G. J., Bollen, E. L.E.M., Buckley, B. M., Cobbe, S. M., Ford, I., Gaw, A., Hyland, M., Jukema, J. W., Kamper, A. M., Macfarlane, P. W., Murphy, M. B., Packard, C. J., Perry, I. J., Stott, D. J., Sweeney, B. J., Twomey, C., Westendorp, R. G.J., Shepherd, J., for the PROSPER Study Group, (2007). C-Reactive Protein and Prediction of Coronary Heart Disease and Global Vascular Events in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER). Circulation 115: 981-989 [Abstract] [Full Text]  
• Heart Protection Study Collaborative, (2006). Lifetime cost effectiveness of simvastatin in a range of risk groups and age groups derived from a randomised trial of 20 536 people. BMJ 333: 1145-1145 [Abstract] [Full Text]  
• Ajjan, R. A, Grant, P. J (2006). Cardiovascular disease prevention in patients with type 2 diabetes: the role of oral anti-diabetic agents. Diabetes and Vascular Disease Research 3: 147-158 [Abstract]  
• Wierzbicki, A. S (2006). Fibrates after the FIELD study: some answers, more questions. Diabetes and Vascular Disease Research 3: 166-171 [Abstract]  
• Brindle, P, Beswick, A, Fahey, T, Ebrahim, S (2006). Accuracy and impact of risk assessment in the primary prevention of cardiovascular disease: a systematic review. Heart 92: 1752-1759 [Abstract] [Full Text]  
• (2006). Spoken sessions. Thorax 61: ii3-ii56 [Full Text]  
• Williams, B. (2006). The Year in Hypertension. J Am Coll Cardiol 48: 1698-1711 [Full Text]  
• Mackenzie, D G., Wild, S. H, Rutledge, P. (2006). Are eligibility criteria for over the counter statins appropriate?. BMJ 333: 704-704 [Full Text]  
• Mcelduff, P, Jaefarnezhad, M, Durrington, P N (2006). American, British and European recommendations for statins in the primary prevention of cardiovascular disease applied to British men studied prospectively. Heart 92: 1213-1218 [Abstract] [Full Text]  
• (2006). Statins for primary prevention in type 2 diabetes. DTB 44: 57-60 [Abstract] [Full Text]  
• Gholap, N., Pillai, M., Virmani, S., Lee, J. D, James, D., Morrissey, J., Datta, V., Patel, V. (2006). The Alphabet Strategy and standards of care in young adults with type 1 diabetes. British Journal of Diabetes & Vascular Disease 6: 168-170 [Abstract]  
• Duerden, M. G (2006). Should we lower cholesterol as much as possible?: Policy on high dose statins is startlingly absent.. BMJ 332: 1452-1453 [Full Text]  
• Mccallum, R. W, Fisher, M. (2006). Review: Comparing cardiovascular outcomes in diabetes studies. British Journal of Diabetes & Vascular Disease 6: 111-118 [Abstract]  
• Raghavan, R. P, Laight, D. W, Shaw, K. M, Cummings, M. H (2006). Review: Aspirin and diabetes. British Journal of Diabetes & Vascular Disease 6: 74-82 [Abstract]  
• Da Costa, S. (2006). Recognition and management of cardiovascular risk factors in type 2 diabetes. British Journal of Diabetes & Vascular Disease 6: S2-S6 [Abstract]  
• Fisher, M., Campbell, I. W (2006). Residual cardiovascular risk and practical management of type 2 diabetes. British Journal of Diabetes & Vascular Disease 6: S17-S23 [Abstract]  

eLetters:

Read all eLetters

Use of nicotinic acid in JBS2

Tony Patrikios

Online, 18 Jan 2006 [Full text]